| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/22/2013 | US8357774 Polypeptide and process for producing the same |
| 01/22/2013 | US8357692 Methods of treatment of bone degenerative diseases |
| 01/22/2013 | US8357670 Oligomeric compounds for the modulation of HIF-1A expression |
| 01/22/2013 | US8357669 Method of treatment for lymphedema comprising administering a polynucleotide encoding VEGF-D |
| 01/22/2013 | US8357662 Surface-based ammonium ion sensor and methods of making thereof |
| 01/22/2013 | US8357661 Recombinant human Alpha1-antitrypsin |
| 01/22/2013 | US8357660 Methods for inhibiting growth of prolactin-responsive cancer cells with cyclosporine A or other cyclophilin inhibitors |
| 01/22/2013 | US8357659 Method of treating pain or itching with APETx2 peptide toxin |
| 01/22/2013 | US8357657 Therapeutic combination comprising a pulmonary surfactant and a steroid |
| 01/22/2013 | US8357654 Multimeric CD40 ligands, method for preparing same and use thereof for preparing drugs |
| 01/22/2013 | US8357653 System and method for inhibiting cellular proliferation with tachykinins |
| 01/22/2013 | US8357652 Anti-tumor fibrillar human serum albumin methods and compositions |
| 01/22/2013 | US8357515 Latency associated protein construct with aggrecanase sensitive cleavage site |
| 01/22/2013 | US8357501 Tissue protective erythropoietin receptor (NEPOR) and methods of use |
| 01/22/2013 | US8357494 Anti-clusterin oligoclonal antibodies for diagnosis and prediction of the aggressiveness of tumours, diagnostic method and related kits |
| 01/22/2013 | US8357402 Flowable wound matrix and its preparation and use |
| 01/22/2013 | US8357399 Tamper-resistant oral opioid agonist formulations |
| 01/22/2013 | US8357390 Drug eluting implantable medical device with hemocompatible and/or prohealing topcoat |
| 01/22/2013 | US8357388 Drug depot implant designs and methods of implantation |
| 01/22/2013 | US8357372 Agent for treating allergic or hypersensitivity condition |
| 01/22/2013 | US8357368 Methods of treating pancreatic or liver cancer using hedgehog antagonists |
| 01/22/2013 | US8357363 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 01/22/2013 | US8357362 Treating non-hematopoietic cancer with interleukin 6 |
| 01/22/2013 | CA2771215C Therapeutic preparation for rhinitis |
| 01/22/2013 | CA2667031C Hcv ns3 protease inhibitors |
| 01/22/2013 | CA2653939C Immunostimulatory oligonucleotides and use thereof in pharmaceuticals |
| 01/22/2013 | CA2608747C Elastin producing fibroblast formulations and methods of using the same |
| 01/22/2013 | CA2588965C Novel chimeric plasminogen activators and their pharmaceutical use |
| 01/22/2013 | CA2565051C Novel use of peptide compounds for treating dyskinesia |
| 01/22/2013 | CA2560241C Carbohydrate-derivatized liposomes for targeting cellular carbohydrate recognition domains of ctl/ctld lectins, and intracellular delivery of therapeutically active compounds |
| 01/22/2013 | CA2537250C Topical preparations comprising a hydrophilic carrier and a silicone matrix |
| 01/22/2013 | CA2536735C Methods for determining cd8+ t-cell epitopes |
| 01/22/2013 | CA2493487C Method for isolating an intestinal cholesterol binding protein |
| 01/22/2013 | CA2489515C Methods and compositions for modulating and detecting wisp activity |
| 01/22/2013 | CA2483819C Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus |
| 01/22/2013 | CA2483525C Method of measuring neprilysin activity |
| 01/22/2013 | CA2452582C G-csf conjugates |
| 01/22/2013 | CA2448607C Colloidal metal compositions and methods |
| 01/22/2013 | CA2441970C Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 01/22/2013 | CA2425862C Cd19-specific redirected immune cells |
| 01/22/2013 | CA2400610C Endoparasiticidal compositions comprising a cyclic depsipeptide |
| 01/22/2013 | CA2346122C Stabilized bioactive peptides and methods of identification, synthesis and use |
| 01/22/2013 | CA2343716C Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 01/22/2013 | CA2338524C Inhibitors of urokinase and blood vessel formation |
| 01/22/2013 | CA2337574C Hematopoietic stem cell expansion enhancing factor and method of use |
| 01/22/2013 | CA2329267C A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upflp, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 01/22/2013 | CA2325629C Crystalline forms of 1s-[1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-[[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino[1, 2-a][1,2] diazepin- 1-carboxamide |
| 01/17/2013 | WO2013010140A2 Methods of diagnosing cancer |
| 01/17/2013 | WO2013010100A1 Methods for treatment of incontinence associated with sexual activity |
| 01/17/2013 | WO2013010069A1 Modified viral structural protein with antiviral activity |
| 01/17/2013 | WO2013010028A2 COMPOSITIONS AND METHODS FOR IMPROVED CaMKII INHIBITORS AND USES THEREOF |
| 01/17/2013 | WO2013009979A2 Compositions and methods for suppressing gene expression of p53 and clusterin |
| 01/17/2013 | WO2013009943A2 Micro-utrophin polypeptides and methods |
| 01/17/2013 | WO2013009910A2 Eosinophil peroxidase compositions and methods of their use |
| 01/17/2013 | WO2013009885A2 Evaluation of copolymer diethylamide |
| 01/17/2013 | WO2013009864A1 Structure assessment of heterogeneous polypeptide mixtures |
| 01/17/2013 | WO2013009790A2 A heat stable oxygen carrier-containing pharmaceutical composition for different treatment applications |
| 01/17/2013 | WO2013009755A2 Method of use of activated functional proteins to improve animal health |
| 01/17/2013 | WO2013009647A1 Glutathione analogs and uses thereof |
| 01/17/2013 | WO2013009627A2 Factor viii chimeric and hybrid polypeptides, and methods of use thereof |
| 01/17/2013 | WO2013009625A1 Method for treatment of autonomic nervous system disorders |
| 01/17/2013 | WO2013009584A1 Method for treatment of esophageal spasm |
| 01/17/2013 | WO2013009539A1 Engineered polypeptides having enhanced duration of action and reduced immunogenicity |
| 01/17/2013 | WO2013009165A1 A peptide capable of binding with a human leukocyte antigen (hla) molecule, a cancer vaccine derived from said peptide and use of said cancer vaccine |
| 01/17/2013 | WO2013008743A1 Chlamydophila pneumoniae antigen and usage thereof |
| 01/17/2013 | WO2013008681A1 Pharmaceutical composition for preventing or treating fibrosis |
| 01/17/2013 | WO2013007933A1 Antagonist peptide of the bond between cd47 and a protein belonging to the thrombospondin family |
| 01/17/2013 | WO2013007772A1 Hbv polymerase mutants |
| 01/17/2013 | WO2013007704A2 Novel sdf-1-based glycosaminoglycan antagonist and methods of using same |
| 01/17/2013 | WO2013007596A2 Oral treatment of inflammatory bowel disease |
| 01/17/2013 | WO2013007003A1 Novel use of acetylacetic acid for regulating proliferation of skeletal-muscle cells |
| 01/17/2013 | WO2013006978A1 Neuroprotective pepties that inhbit interaction between palmitoyl acyl transferase zinc- finger dhhc type containing 17 (zd17) and c-jun n-terminal kinase (jnk) |
| 01/17/2013 | WO2013006956A1 Methods and uses of a modified cecropin for treating endoparasitic and bacterial infections |
| 01/17/2013 | WO2013006948A1 Methods and compositions for enhancing developmental potential of oocytes and preimplantation embryos |
| 01/17/2013 | WO2012158866A9 Treatment of autoimmune disorders and infections using antagonists of sgk1 activity |
| 01/17/2013 | WO2012149376A3 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same |
| 01/17/2013 | WO2012148200A3 Composition for aiding surgical procedures for treating ischemic vascular diseases |
| 01/17/2013 | WO2012145651A3 Compounds for the treatment of neuropsychiatric disorders |
| 01/17/2013 | WO2012145428A3 Altering protein concentrations in cerebrospinal fluid and/or brain interstitial fluid |
| 01/17/2013 | WO2012144778A3 Surface-active collagen barrier membrane to which a peptide is bound |
| 01/17/2013 | WO2012142083A3 C1q/tnf-related protein 12 and compositions and methods of using same |
| 01/17/2013 | WO2012138919A3 Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15) |
| 01/17/2013 | WO2012138599A3 Hepatocyte growth factor mimics as therapeutic agents |
| 01/17/2013 | WO2012135818A3 Cancer diagnostics, therapeutics, and drug discovery associated with macropinocytosis |
| 01/17/2013 | WO2012119072A3 Compositions and methods for treatment of intracellular damage |
| 01/17/2013 | WO2012112489A3 Compositions and methods for the therapy and diagnosis of influenza |
| 01/17/2013 | WO2012109561A3 Tripeptide compositions and methods for treatment of diabetes |
| 01/17/2013 | WO2012082950A3 Chimeric fibronectin matrix mimetics and uses thereof |
| 01/17/2013 | US20130018481 Coated stents and process for coating with protein |
| 01/17/2013 | US20130018299 Nanoshells on polymers |
| 01/17/2013 | US20130018089 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides |
| 01/17/2013 | US20130018004 Novel Protein Peptide Hydrogels |
| 01/17/2013 | US20130018003 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
| 01/17/2013 | US20130018002 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
| 01/17/2013 | US20130018001 Methods of diagnosing cancer |
| 01/17/2013 | US20130018000 Recombinant filaggrin polypeptides for cell importation |
| 01/17/2013 | US20130017999 Methods and Compositions for Evaluating and/or Treating Chronic Immune Diseases |
| 01/17/2013 | US20130017998 Novel modified galectin 9 proteins and use thereof |
| 01/17/2013 | US20130017997 Factor VIII Compositions and Methods of Making and Using Same |
| 01/17/2013 | US20130017996 Muteins of tear lipocalin and methods for obtaining the same |